Search
for
Sort by
Research 841–870 of 1000+
- Alopecia.
- Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss
- Pilomatricoma arising at a BCG vaccination site
- Chemical pharmacotherapy options for managing adult acne
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers
- A Case of Rhupus with Rowell Syndrome
- TRICHOPATHOPHOBIA.
- Smurf2-induced degradation of SMAD2 causes inhibition of hair follicle stem cell differentiation
- American Society for Laser Medicine and Surgery - 2018 Late-Breaking Abstracts
- Graft-versus-host disease with acute hair loss: A distinctive manifestation of chronic graft-versus-host disease
- SUCCESSFUL 28-DAY COMBINATION THERAPY OF MALASSEZIA DERMATITIS IN A 1-YEAR-OLD MIXED SMALL-BREED DOG: A CASE REPORT
- Endocrinologia e Medicina Estética Ed. X
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- Hashimoto Thyroiditis - A Comprehensive Review
- Non-Invasive Techniques for Evaluating Alopecia Areata
- 033 IL-15 is an unexpected guardian of hair follicle immune privilege and promotes human hair growth ex vivo
- DERMOSCOPIC EVALUATION OF THERAPEUTIC RESPONSE IN ALOPECIA AREATA
- Therapies
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Treatment of Alopecia with Low-Level Light Therapy
- Treatment of pseudofolliculitis barbae with the diode laser
- Evaluation of eyebrow position and upper eyelid laxity after endolift laser treatment
- Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Choroidal Melanoma and Lid Fibrofoliculomas in Birt-Hogg-Dubé Syndrome
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials